Marc E. Lippman is Director at SEATTLE GENETICS INC /WA (SGEN). They have made 10 open-market trades across 1 company since 2007, most recently 2021-05-14.
CIK 0001202794
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $403K since 2007, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SGEN | 53,740 | $12.3M |
Shares reported on the most recent Form 4, priced at the 2021-05-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SGEN | SELL | 2020-11-03 | 2020-11-05 | $168.63 | $44.9M | -4.7% | -1.3% | -10.2% |
| SGEN | SELL | 2020-05-04 | 2020-05-06 | $152.03 | $152K | -5.4% | -11.7% | -1.7% |
| SGEN | SELL | 2019-11-18 | 2019-11-20 | $115.68 | $6.1M | -1.2% | -2.6% | -0.3% |
| SGEN | SELL | 2018-07-31 | 2018-08-02 | $69.25 | $512K | +4.2% | +7.6% | -21.6% |
| SGEN | SELL | 2017-11-15 | 2017-11-17 | $58.07 | $174K | +2.2% | -12.1% | -8.0% |
| SGEN | SELL | 2016-11-07 | 2016-11-09 | $57.75 | $58K | +3.8% | -6.7% | -12.5% |
| SGEN | SELL | 2012-12-05 | 2012-12-07 | $25.54 | $575K | -17.1% | -4.5% | -4.5% |
| SGEN | BUY | 2010-06-04 | 2010-06-08 | $12.49 | $250K | -17.1% | -4.5% | -4.5% |
| SGEN | BUY | 2010-05-10 | 2010-05-12 | $11.92 | $132K | -17.1% | -4.5% | -4.5% |
| SGEN | BUY | 2007-09-17 | 2007-09-20 | $10.62 | $21K | -17.1% | -4.5% | -4.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.